Japan Locally Advanced Pancreatic Cancer Market Forecast (2025–2033): Key Trends & Insights
The Japan Locally Advanced Pancreatic Cancer (LAPC) market was valued at approximately USD 47.09 million in 2024 and is projected to reach USD 89.04 million by 2033 , growing at a CAGR of 7.4% during the forecast period. This growth is driven by advancements in precision medicine, increasing adoption of biomarker-driven therapies, and strong government healthcare support. LAPC refers to a stage of pancreatic cancer where the tumor remains confined to the pancreas and surrounding regional structures but has not metastasized to distant organs. In Japan, LAPC is often classified as unresectable due to the tumor's involvement with critical nearby structures, making non-surgical treatment modalities the primary standard of care. For Sample Report: https://www.datamintelligence.com/download-sample/japan-locally-advanced-pancreatic-cancer-market Key Market Trends and Latest Developments In December 2024, Zai Lab Limited and Novocure announced positive results from the Phase 3 PANOVA-...